Back to List View Graph View

Platelet glycoprotein 4 (CD36)

CD36 is a multifunctional membrane glycoprotein and scavenger receptor with broad roles in lipid handling, innate immunity, and cellular signaling.

Where the papers sit

11 papers from the last 6 months study Platelet glycoprotein 4 (CD36) directly · updated from PubMed 13 Nov 2026

Study type 0 clinical trials · 1 human data · 8 preclinical · 2 unclassified

Themes one subject · 1 paradigm shift

Those 11 are all about one subject.

  • CD36 in Metabolic Inflammation

    CD36 recurs as a lipid-uptake regulator linking macrophage activity, hepatic steatosis, cardiac aging and inflammatory signaling. Liver studies connect CD36 to MASLD, fibrosis and endothelial inflammation through USP12, CA3, exosomal miR-122-5p and the gut–liver axis. Dietary and pharmacologic interventions, including ketogenic diet, chlorogenic acid and celastrol, aim to reduce CD36-associated lipid accumulation. Cancer immunotherapy remains constrained by limited functional activity and an antigen sink, leaving context-specific CD36 targeting unresolved.

    11 papers

PARADIGM SHIFT

CD36 inhibition is not a generally reliable therapeutic strategy

The macrophage-targeted cancer immunotherapy study 43019322Nov and the radiation-response study in murine macrophages 42992867Nov challenge the recurring assumption that reducing CD36 activity will broadly relieve disease-associated inflammation or macrophage dysfunction. In the cancer models, anti-CD36 antibodies blocked ligand binding in engineered systems but failed to produce consistent responses in primary macrophages and did not reproduce the tumor-suppressive effect of CD36 genetic deletion, in part because of an antigen sink. In the radiation model, by contrast, CD36 was induced in macrophages after irradiation, and pharmacological inhibition increased radiation-associated macrophage apoptosis and inflammatory responses. Together, these findings show that CD36 inhibition can fail because drug blockade does not recapitulate genetic loss and can worsen injury when CD36 forms part of an adaptive response, making disease context and intervention modality decisive rather than treating CD36 blockade as a generally transferable strategy.

Papers

The 11 papers from the last 6 months that study Platelet glycoprotein 4 (CD36) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

CD36 in Metabolic Inflammation (11)
  1. Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy. PloS one · 12 Nov 2026 PMID 43019322
  2. Transcriptomics-Coupled Proteomics Identifies CD36 as a Potential Radiation-Responsive Biomarker in Macrophages. Journal of proteome research · 6 Nov 2026 PMID 42992867
  3. Ketogenic diet attenuates cardiac aging through inhibiting CD36/MAPK-mediated lipid accumulation: Comparable effects in aged male and female mice. Experimental gerontology · 7 Oct 2026 PMID 42843434
  4. Integrative Single-Cell Transcriptomics, Multi-Omics Analyses, and Computational Pharmacology Reveal Macrophage Heterogeneity and the Putative THBS1-CD36 Axis in Coronary Atherosclerosis. Chemical biology & drug design · 29 Sept 2026 PMID 42811239
  5. A ROS-responsive platelet extracellular vesicle biomimetic nanosystem regulates CD36/Fyn-CXCL-NETosis pathway-mediated immune-inflammatory amplification in the treatment of transfusion-related acute lung injury. Redox biology · 9 Sept 2026 PMID 42715911
  6. Sinusoidal endothelial cells orchestrate liver inflammation and lipid metabolism via USP12/CD36 axis being the target of celastrol therapy. Biochimica et biophysica acta. Molecular basis of disease · 8 Sept 2026 PMID 42710599
  7. Human stem cell-derived hepatic cells recapitulate polygenic risk in MASLD development and highlight CD36 as a key mediator. Life sciences · 13 Jul 2026 PMID 42442603
  8. Dietary chlorogenic acid improves lipid metabolism through modulation of the gut-liver microbiota axis in hyperlipidemic mice. Food & function · 16 Jun 2026 PMID 42300531
  9. Nano- and microplastics induce size specific adipogenic and metabolic dysregulation. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 11 Jun 2026 PMID 42276152
  10. Steatotic hepatocyte-derived exosomes increase free fatty acids uptake by transporting miR-122-5p to target ATP6V1H-mediated CD36 translocation in hepatocytes. Clinical science (London, England : 1979) · 5 Jun 2026 PMID 42244364
  11. 1-Naphthol Drives Liver Steatosis and Fibrosis via the CA3-CD36 Axis Independent of Obesity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 27 May 2026 PMID 42201771

By study type

Human data, design not indexed (1)
  1. Integrative Single-Cell Transcriptomics, Multi-Omics Analyses, and Computational Pharmacology Reveal Macrophage Heterogeneity and the Putative THBS1-CD36 Axis in Coronary Atherosclerosis. Chemical biology & drug design · 29 Sept 2026 PMID 42811239
Preclinical: animal, cell and lab studies (8)
  1. Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy. PloS one · 12 Nov 2026 PMID 43019322
  2. Transcriptomics-Coupled Proteomics Identifies CD36 as a Potential Radiation-Responsive Biomarker in Macrophages. Journal of proteome research · 6 Nov 2026 PMID 42992867
  3. Ketogenic diet attenuates cardiac aging through inhibiting CD36/MAPK-mediated lipid accumulation: Comparable effects in aged male and female mice. Experimental gerontology · 7 Oct 2026 PMID 42843434
  4. A ROS-responsive platelet extracellular vesicle biomimetic nanosystem regulates CD36/Fyn-CXCL-NETosis pathway-mediated immune-inflammatory amplification in the treatment of transfusion-related acute lung injury. Redox biology · 9 Sept 2026 PMID 42715911
  5. Dietary chlorogenic acid improves lipid metabolism through modulation of the gut-liver microbiota axis in hyperlipidemic mice. Food & function · 16 Jun 2026 PMID 42300531
  6. Nano- and microplastics induce size specific adipogenic and metabolic dysregulation. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 11 Jun 2026 PMID 42276152
  7. Steatotic hepatocyte-derived exosomes increase free fatty acids uptake by transporting miR-122-5p to target ATP6V1H-mediated CD36 translocation in hepatocytes. Clinical science (London, England : 1979) · 5 Jun 2026 PMID 42244364
  8. 1-Naphthol Drives Liver Steatosis and Fibrosis via the CA3-CD36 Axis Independent of Obesity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 27 May 2026 PMID 42201771
Unclassified: not yet indexed with MeSH (2)
  1. Sinusoidal endothelial cells orchestrate liver inflammation and lipid metabolism via USP12/CD36 axis being the target of celastrol therapy. Biochimica et biophysica acta. Molecular basis of disease · 8 Sept 2026 PMID 42710599
  2. Human stem cell-derived hepatic cells recapitulate polygenic risk in MASLD development and highlight CD36 as a key mediator. Life sciences · 13 Jul 2026 PMID 42442603